ISMPP Highlights
ISMPP Announces Artificial Intelligence Position Statement and Call to Action
ISMPP is thrilled to announce that its highly-anticipated ISMPP Position Statement and Call to Action on Artificial Intelligence (AI) was published today, November 1, 2023, in Current Medical Research and Opinion (CMRO)…
Inaugural ISMPP Academy Draws Strong Attendance to Philadelphia
ISMPP Academy was a great success leaving attendees equipped with new knowledge, practical tools, and a strengthened network to propel their careers in medical communications and publications. We look forward to the continued growth and success of ISMPP Academy in the years to come. Thank you to everyone who contributed to this remarkable event!
GPP 2022 in Asia Pacific: Translations & Presentations
Since publication of GPP 2022 for company-sponsored research in Annals of Internal Medicine just over one year ago, various presentations have addressed audiences in the Asia Pacific region. ISMPP is also now pleased to announce that translations of GPP 2022 into both Chinese and Japanese are available!
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Mastering the Art of Meeting Facilitation: Part 1
Meetings serve as vital platforms for collaboration and discussion as well as ensuring key decisions are made for aspects critical to successful publication planning. This is the first of two articles that will provide tips and insights into running a successful meeting. Initially, in this article, we look at preparation and what a facilitator should focus on to ensure success…
Author Payments: Same Policies, Different Scope
Can we pay authors for work that leads to a publication? This is a pressing question often faced by medical publication professionals. Good Publication Practice 2022 (GPP 2022) and its predecessors provided guidance on author payments. New questions on author payments and corresponding GPP 2022 guidance are addressed here, as well as further explanation of GPP 2022 wording and expanded scope compared with earlier GPP iterations…
Copyright Confusion: Demystifying Creative Commons Licenses for Industry-Funded Research
Have you ever published a journal article open access? If so, you might be familiar with Creative Commons (CC) licenses. This series of copyright licenses was designed as an alternative to standard copyright models, allowing authors to retain copyright of their work while setting the conditions for the reuse of the work…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
To Use AI or To Not Use AI… for Manuscript Development? [redo]
You are a researcher working on a groundbreaking clinical study that could potentially lead to a significant advancement in the treatment of a complex disease. Some members of the research team want to use artificial intelligence (AI) to develop the first draft of the manuscript. Other team members are concerned about accuracy, interpretation, and potential bias in the content. What Would You Do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals